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ABSTRACT
Many studies have shown that probiotic strains added to a number of probiotic products are not compatible to that of 
claimed. It is thus of note to validate probiotic strains added to probiotic products. In this study, three probiotic drinks, 
A, B and C, were cultured on MRS agar and the number of bacterial colonies was enumerated. The bacterial counts 
recovered from A (9.3 ± 6.9 log CFU/ml) and C (9.0 ± 6.9 log CFU/ml) were signifi cantly higher than B (5.2 ± 3.5 log 
CFU/ml) and achieved the minimal amount recommended for probiotic bacteria. All of the isolates appeared as gram 
positive rods microscopically and were proven to be catalase negative. However, there were only A1, A2, B4 and C1 that 
were highly tolerant to the gastrointestinal pH 3 to 6. The four isolates produced and secreted antimicrobial substances 
which inhibited the growth of Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). C1 showed the greatest 
growth inhibition by forming 17.50-mm and 17.85-mm inhibition zones against E. coli and S. aureus, respectively. The 
16s rDNA sequencing and phylogenetic analysis were performed to further identify the twelve isolates. The twelve isolates 
were found to be Lactobacillus (L.), particularly L. casei and L. paracasei. However, the bacteria isolated from drink B 
were incompatible to the labelled ones. In conclusion, probiotic drinks are possible to contain different bacterial counts 
and probiotic strains from the labelled ones. These differences might affect health benefi ts rendered by probiotic strains 
to consumers.
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ABSTRAK
Banyak kajian telah menunjukkan bahawa strain probiotik yang ditambah ke dalam kebanyakan produk probiotik adalah 
tidak sepadan dengan yang dinyatakan. Oleh itu, amatlah penting bagi mengesahkan strain probiotik yang ditambah 
ke dalam produk probiotik. Dalam kajian ini, tiga minuman probiotik iaitu A, B dan C dikulturkan di atas agar MRS dan 
jumlah koloni bakteria dikira. Jumlah bakteria yang dipulihkan daripada minuman probiotik A (9.3 ± 6.9 log CFU/ml) 
dan C (9.0 ± 6.9 log CFU/ml) adalah lebih tinggi secara signifi kan daripada B (5.2 ± 3.5 log CFU/ml) serta mencapai 
bilangan minimum yang disarankan untuk bakteria probiotik. Kesemua pencilan muncul dalam bentuk rod gram positif 
secara mikroskopik dan juga dibuktikan negatif dalam ujian katalase. Namun, hanya pencilan A1, A2, B4 dan C1 yang 
bertahap toleransi yang tinggi terhadap pH gastrousus 3 hingga 6. Kempat-empat pencilan tersebut menghasilkan dan 
merembeskan bahan antimikrob yang dapat merencatkan pertumbuhan Escherichia coli (E. coli) serta Staphylococcus 
aureus (S. aureus). C1 menunjukkan tahap perencatan tertinggi dengan membentuk zon perencatan seluas 17.50-mm 
dan 17.85-mm masing-masing terhadap E. coli serta S. aureus. Penjujukan rDNA 16s dan analisis fi logenetik dilakukan 
bagi mengenal pasti dua belas pencilan tersebut. Kesemua pencilan tersebut merupakan Lactobacillus (L.), terutamanya 
L. casei and L. paracasei. Namun bakteria yang dipencilkan daripada minuman B adalah tidak sepadan dengan yang 
dilabelkan. Kesimpulannya, minuman probiotik berkemungkinan untuk mengandungi bilangan bakteria dan strain 
probiotik yang berbeza daripada yang dilabelkan. Perbezaan demikian mungkin mempengaruhi manfaat kesihatan 
strain probiotik kepada pengguna.
Kata kunci: Probiotik; bakteria asid laktik; antimikrob; toleransi pH
INTRODUCTION
Increasing consumer awareness towards healthy diet has 
created a huge market demand for a variety of functional 
foods with benefi cial health effects. Probiotic food is 
defi ned as “food containing live microorganisms which are 
believed to actively enhance health by improving the balance 
of microfl ora in the gut” (Mattila-Sandholm et al. 2002). 
Probiotic bacteria mainly consist of lactic acid bacteria 
(LAB) such as Streptococcus thermophilus, Lactobacillus 
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bulgaricus, Lactobacillus lactis, Lactobacillus acidophilus 
and Lactobacillus casei (Galal et al. 2012). 
Numerous studies have reported that consumption 
of probiotic LAB confers many forms of health benefi ts 
to hosts. For instance, probiotic LAB have been shown to 
produce antimicrobial compounds, modulate host defense 
and exhibit antimutagenic properties (Adolfsson et al. 
2004). The antimicrobial compounds produced by probiotic 
strains encompass lactic acid, acetic acid, hydrogen 
peroxide and bacteriocins (Saarela et al. 2000; Cotter et al. 
2005). These antimicrobial compounds have been shown 
to prevent the colonization of pathogenic microorganisms 
such as Salmonella enteritidis (Thirabunyanon and 
Thongwittaya 2012) and Candida albicans (Wagner 
and Johnson 2012). Probiotic bacteria are also potent 
innate immune stimulators. They activate innate immune 
responses via interactions with pattern recognition 
receptors (PRRs) which then initiate the production of 
pro-infl ammatory cytokines such as TNF-α and IL-1β. 
Pro-infl ammatory cytokines are crucial for phagocyte 
recruitment in pathogen elimination (Kamada et al. 2013). 
Members of Lactobacillus and Bifi dobacterium have been 
proven to possess signifi cant antimutagenicity against food 
mutagens (Settanni and Moschetti 2010). Matsumoto and 
Benno (2004) reported that the gut mutagenicity in healthy 
adults was substantially reduced following the consumption 
of Bifi dobacterium lactis LKM512 yogurt. These evidences 
prove that probiotic bacteria indeed bring goodness to 
human health. A suffi cient amount of viable probiotic 
bacteria must reach the intestines in order to for the bacteria 
to establish optimal health benefi ts in hosts. Lourens et al. 
(2000) suggested that the minimum therapeutic dose of 
probiotic bacteria is 105 to 109 CFU/day. The bacteria must 
also be able to survive the acidic microenvironment in the 
stomach and resist bile acid at the beginning of the small 
intestine (Holzapfel et al. 1998).
Owing to the extensive use of probiotic strains in 
functional food, it has led to poor quality control by 
manufacturers. Several studies have reported that contents 
of probiotic products are often not accurately represented 
on their labels; for instance some products do not contain 
the labeled microorganisms but the other species whereas 
the others do not contain the stated LAB counts (Coeuret et 
al. 2004). In this light, this study was done to characterize 
and identify LAB in commercial probiotic drinks available 
in Malaysia. The viability of LAB was determined by 
enumerating the number of LAB recovered from the 
selected probiotic drinks. Probiotic drink B was found to 
contain approximately 4 log CFU/ml less bacterial count 
than A and C. The 16s rDNA sequencing and phylogeny 
results confi rmed that the isolated bacteria were mainly 
Lactobacillus. However, the bacterial strain isolated from 
drink B was totally different from the labelled one. In 
spite of being one of the most prominent probiotic genera, 
there were only four isolates (A1, A2, B4 and C1) which 
could survive gastric pH 3. These four isolates produced 
and secreted antimicrobial substances that caused the 
formation of inhibition zones against Escherichia coli and 
Staphylococcus aureus on Mueller-Hinton (MH) agar. This 
study has shown that it is possible for probiotic products 
to contain different probiotic strains and counts from that 
of claimed. Furthermore, characteristics and benefi ts of 
probiotic bacteria such as pH tolerance and antimicrobial 
activities have also been substantiated to be strain- or 
isolate-dependent in this study. These evidences hence 
stress the importance of authenticating and characterizing 
probiotic strains added to probiotic products for the sake 
of consumers’ health. 
MATERIALS AND METHODS
CULTIVATION OF LAB FROM PROBIOTIC DRINKS
An amount of 0.5 ml of probiotic drinks A, B and C were 
diluted in 4.5 ml of phosphate buffer saline (PBS; 4.3 mM 
Na2HPO4, 137 mM NaCl, 2.7 mM KCl, 1.4 mM KH2PO4; 
pH 7.6) and serial dilutions were made from 10-1 to 10-4. 
Then, 0.1 ml of 10-3 and 10-4 dilutions were cultured on 
de Man, Rogosa and Sharpe (MRS) (Sigma-Aldrich, St. 
Louis, United States) agar plates and incubated for 48 
h at 37°C. The bacterial colonies were enumerated and 
recorded as colony forming units (CFU). Twelve colonies 
were selected randomly as recommended in Bailey et al. 
(1979) from probiotic drinks A, B and C for gram-staining 
and catalase test. 
CATALASE TEST
An amount of 3.0 ml (3%, v/v) hydrogen peroxide 
was aliquoted into test tubes. The twelve isolates were 
inoculated separately into the test tubes. For positive 
control, a single colony of Staphylococcus aureus (S. 
aureus) ATCC 25923 was inoculated into one of the test 
tubes. PBS buffer (pH7.6) was used as negative control. 
Formation of bubbles denoted the presence of catalase and 
the test was positive, otherwise, the results were recorded 
as negative.
pH TOLERANCE
Twelve isolates were inoculated separately into 5 ml of 
MRS broth and incubated at 37°C until OD600 reached 1.0 
(equivalent to 8 log CFU/ml). The bacteria were spun down 
at 4000 x g (Beckman Coulter, California, United States) 
for 5 min and subsequently washed with PBS buffer. The 
centrifugation and washing steps were repeated twice. The 
pellet was dissolved in 5 ml of PBS at pH3-6 and incubated 
at 37°C for 2 h. The bacterial suspension was diluted 300 
times and 10 μl of bacterial suspension were cultured on 
MRS agar plates. The plates were incubated at 37°C for 48 
h. The viability of bacteria was determined by quantifying 
the CFU on the plates.
JSKM13(1) 4.indd   24 16/06/2015   12:10:06
25
ANTIMICROBIAL TEST
LAB must survive gastric pH in order to be functional in the 
gastrointestinal tract (Mattila-Sandholm et al. 2002). There 
were four isolates (A1, A2, B4 and C1) surviving pH3-6 in 
the pH tolerance test, they were therefore further analyzed 
for their antimicrobial ability. The isolates were inoculated 
separately into 5 ml of MRS broth. The cultures were 
incubated at 37°C until OD600 reached 1.0. The bacterial 
cells were spun down at 4000 x g for 5 min. The separated 
broth was sterilized with a membrane filter (0.2 μm; 
Eppendorf, Hamburg, Germany). The indicator bacteria, 
Escherichia coli (E. coli) strain Top 10 (Invitrogen, New 
York, United States), and S. aureus ATCC 25923, were 
initially cultured on MHA plates and allowed to dry for 30 
min. Sterile 6-mm discs were dipped into 50 μl of sterilized 
broth and placed on MHA plates cultured with the indicator 
bacteria. The ampicillin discs (10 mg/ml; Oxoid Thermo 
Scientifi c, Leicestershire, United Kingdom) served as 
positive control. The plates were incubated at 37°C for 24 
h. According to the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) (Matuschek et al. 2013), 
E. coli and S. aureus are susceptible to ampicillin if the 
inhibition zone diameters are > 14+1 mm and > 18+1 mm, 
respectively. This standard was employed to validate the 
test reliability. 
DNA EXTRACTION
Twelve isolates were cultured separately in MRS broth. A 
total of 1.5 ml bacterial culture was transferred into a sterile 
microcentrifuge tube and spun at 4000 xg for 5 min. The 
broth was discarded and the pellet was dissolved in 500 μl 
resuspending buffer [440 μl Tris-NaCl (50 mM Tris-HCl, 
pH 8.0, 1 mM EDTA, pH8.0; 100 mM NaCl), 5 μl lysozyme 
(20 mg/ml), 50 μl 1% (w/v) sodium dodecyl sulfate (SDS) 
and 6 μl proteinase K (10 mg/ml)]. The suspension was 
incubated for 1 h at 37°C. After incubation, 470 μl of 
phenol:chloroform (1:1) was added into cell suspension 
and mixed evenly. The cell suspension was centrifuged 
at 4000 xg for 5 min. The aqueous phase was transferred 
into a new microcentrifuge tube. About 20 μl of sodium 
acetate (3 M, pH5.2) and 500 μl of isopropanol (Applied 
Biosystems, Foster City, United States) were added to the 
aqueous phase and mixed gently until the deposition of 
the white threads of DNA was observed. A glass Pasteur 
pipette was inserted and rotated slowly until DNA strands 
attached to it. The DNA threads were dipped into 70% (v/v) 
cold ethanol (Applied Biosystems, Foster City, United 
States), air-dried and dissolved in 50 μl cold distilled 
water containing RNase A (20 μg/ml). The DNA solution 
was stored at -20°C.
AMPLIFICATION AND SEQUENCING OF 16S RDNA
The bacterial 16S rDNA gene was amplifi ed from the 
bacterial genome using the universal 16s rDNA primers, 
Forward (5´- GAG TTT GAT CCT GGC TCA G -3´) and Reverse 
(5´-CGG CTA CCT TGT TAC GAC TT-3´). The PCR reaction 
mixture (50 μl) consisting of 10 μl amplifi cation buffer 
(5x), 1 μl dNTP (20 mM), 1.5 μl of each primer (20 μM), 
0.5 μl Go Taq DNA Polymerase (Thermo Scientific, 
Leicestershire, UK), 5 μl MgCl2 (25 mM), 29.5 μl nuclease 
free water and 1 μl template DNA was prepared. The 
thermo-cycling program was set as follows: 94°C for 5 
min; 30 cycles of 94°C for 30 s, 55°C for 90 s, and 72°C 
for 30 s; and a fi nal extension step at 72°C for 10 min. 
The PCR products were analyzed on 1% (w/v) agarose 
gel. The target fragments were excised and purified 
using the HiYield Gel/PCR DNA Fragments Extraction 
Kit (Yeastern Biotech, Taipei, Taiwan) according to the 
manufacturer’s instructions. The purifi ed 16S rDNA was 
sequenced (Nanolifequest, Kuala Lumpur, Malaysia) 
and the sequencing results were compared to that of the 
Genbank database using the Basic Local Alignment Search 
Tool (BLAST) (www.nbci.nlm.nih.gov/genbank).
PHYLOGENETIC TREE RECONSTRUCTION
Phylogeny.fr offers a user-friendly and automated pipeline 
to reconstruct phylogenetic trees for microorganisms of 
interest (Dereeper et al. 2008). The DNA sequences with 
96-99% homology were selected from the BLAST results 
and used as inputs for the phylogenetic tree reconstruction. 
The DNA sequences of two commonly known probiotic 
bacteria were included as outgroups: Bifi dobacterium 
longum subsp. infantis ATCC 15697 and Lactobacillus 
acidophilus. These sequences were then aligned and 
curated to A1-C4 DNA sequences. A phylogenetic tree was 
reconstructed subsequently with the PhyML (Phylogeny 
Maximum Likelihood) and presented using the TreeDyn. 
The PhyML was run with the aLRT (Likelihood Ratio Test) 
statistical test of branch support. 
STATISTICAL ANALYSIS
The signifi cance differences in bacterial counts recovered 
from drinks A, B and C were compared via Kuskal-Wallis 
and Mann-Whitney tests using the SPSS version 20.0 
software. The differences in the inhibition zone diameters 
produced by isolate C1 and ampicillin were compared with 
One-Way ANOVA and Tukey’s HSD tests using the SPSS 
version 20.0 software.
RESULTS AND DISCUSSION
BACTERIAL COUNTS IN PROBIOTIC DRINKS
The probiotic strains, minimum viable bacterial count 
and recovered bacterial count of each drink were 
listed in Table 1. According to the US Food and Drug 
Administration (FDA), it is important to label probiotic 
strains and minimum viable bacterial amount added to 
a probiotic product since probiotic health benefi ts are 
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strain specifi c and also dependent on the number of viable 
microorganisms (Mattila-Sandholm et al. 2002; Saldanha 
2008). It has been suggested that probiotic bacteria should 
be present in food products at a minimum level of 105-109 
CFU/ml (5-9 log CFU/ml) (Lourens et al. 2000). According 
to the product labels, A and C should contain 6 to 7 log 
CFU/ml minimum viable probiotic bacteria. Meanwhile, the 
bacteria counts recovered from A and C were 9.3±6.9 and 
9.0±6.9 log CFU/ml, respectively. The recovered bacterial 
counts not only fell in the range of the minimum level (~9 
log CFU/ml) but were approximately 2 to 3 log CFU/ml 
more than the labelled amounts. It is therefore believed 
that A and C are of better capability in providing health 
benefi ts to consumers. 
TABLE 1. Probiotic contents of drinks A, B and C
 Probiotic drinks Probiotic strains Minimum viable bacterial count Recovered bacterial count
   stated on the product labels (log CFU/ml)*
   (log CFU/ml) 
 A Lactobacillus casei 7 9.3 ± 6.9a
 B Lactobacillus acidophilus, Not mentioned 5.2 ± 3.5
  Bifi dobacterium lactis DR10
 C Lactobacillus casei, Lactobacillus  6 9.0 ± 6.9b
  acidophilus
* The experiment was performed in triplicate and the bacterial count is expressed as log CFU/ml + log standard deviation
a The bacterial count recovered from A was signifi cantly different from that recovered from B, p < 0.043
b The bacterial count recovered from C was signifi cantly different from that recovered from B, p < 0.046
There was no minimum viable bacteria count 
mentioned on the drink B label (Table 1). The probiotic 
bacteria were therefore revived and enumerated on MRS 
agar. The amount was found to be 4 log CFU/ml lower than 
A and C. The statistical signifi cant values were p < 0.043 
(comparison between A and B) and 0.046 (comparison 
between B and C). Despite the differences, the number 
was still within the recommended level. According to Shah 
(2000), the amount of viable probiotic microorganisms in 
a probiotic product and storage condition are contributing 
factors to a relatively low bacterial count recovered from a 
product. However, drinks A, B and C were obtained from 
the same location and stored under the same condition. 
The amounts of viable probiotic bacteria recovered from 
A and C were in accordance to the product labels and the 
recommended level. As a result, storage condition is less 
likely to cause the lower bacterial count recovered from 
B. It is likely that the number of viable probiotic bacteria 
added to drink B was less than A and C and thus resulted 
in low bacterial recovery. 
GRAM STAINING AND CATALASE TEST
Four colonies were selected randomly from each of the 
probiotic cultures on the MRS agar. The characteristics of 
the bacteria were determined using crystal violet and tested 
with hydrogen peroxide. The bacterial isolates appeared as 
purplish-blue (gram positive) and rod-shaped bacilli (data 
not shown) under light microscopic observation. They 
were either single rods or arranged in pairs and chains. 
This fi nding was consistent with that reported by Settanni 
and Moschetti (2010). The high peptidoglycan content in 
gram-positive bacterial cell walls causes retention of crystal 
violet and therefore LAB appear as purple-bluish rods. 
On the other hand, exposure of the isolates to hydrogen 
peroxide did not result in bubble formation and therefore 
resulted in negative catalase test (data not shown). This 
observation was attributable to LAB as anaerobes that are 
unable to produce catalase without the presence of heme 
(König & Fröhlich 2009). Due to the absence of catalase, 
LAB is unable to catalyze the conversion of hydrogen 
peroxide to water and oxygen and thus results in a negative 
catalase test. Altogether, the positive gram-staining and 
negative catalase test proved that the isolates were LAB.
pH TOLERANCE
It is particularly crucial for probiotic bacteria to survive 
acidic environment in the stomach and bile acids in the 
upper small intestine in order to render optimal benefi ts to 
hosts (Mattila-Sandholm et al. 2002). The pH tolerance test 
was carried out in vitro to predict the viability of probiotic 
bacteria after an exposure to the gastric and bile acid pH 
(Rönkä et al. 2009). The twelve isolates were subjected 
to pH3-6 treatments for 2 h. Two-hour incubation was 
performed because the duration represented the retention 
time for bacteria in the gut (Botić et al. 2007). Generally, 
all isolates survived pH4-6 treatments with a minor 
declination at pH6 (Figure 1). The results were similar to 
that reported by Voravuthikunchai et al. (2006) in which 
most of the Lactobacillus strains survived pH4 and 5 in 
vitro. There were only A1, A2, B4 and C1 surviving pH 
3 which represented the gastric pH. This shows that these 
four isolates possessed better pH tolerance than the other 
isolates. According to Vinderola and Reiheimer (2003), 
tolerance to acidic pH is very strain specifi c. In addition, 
Lin et al. (2006) reported that the majority of LAB isolated 
from commercial products only grew moderately at pH3.2. 
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This scenario explains why there were few isolates survived 
pH3.0 in this study. The pH tolerance of probiotic bacteria 
to the gastrointestinal pH can be possibly enhanced by co-
ingestion of milk (Gardiner et al. 2000). 
ANTIMICROBIAL TEST
LAB have long been associated with highly competent 
antimicrobial capabilities in preventing the growth 
of pathogenic bacteria (Settanni & Moschetti 2010; 
Winkelströter et al. 2011). LAB produce and secrete organic 
acids, bacteriosins and nisin into the surroundings, thereby 
inhibit the growth of pathogenic microorganisms (Carr 
et al. 2002; Hartmann et al. 2011). A number of secreted 
antimicrobials have been identifi ed in LAB. For examples, 
organic acids, hydrogen peroxide and bacteriocins. 
Organic acids such as lactic acid and acetic acid lower the 
local pH which in turn retards the growth of pH-sensitive 
pathogens (De Keersmaecker et al. 2006). LAB also produce 
hydrogen peroxide as a strong oxidizing agent in inhibiting 
the growth of pathogenic bacteria (Monteagudo-Mera 
et al. 2012). On the other hand, bacteriocins inhibit the 
growth of gram-positive and gram-negative bacteria by 
permeabilizing the cell membrane and interfering with the 
activities of essential enzymes. 
Since isolates A1, A2, B4 and C1 showed better 
tolerance to pH3-6, these isolates were therefore expected 
to colonize the gastrointestinal tract and exert antimicrobial 
effects better. As previously described, the four isolates 
were also believed to produce and secrete antimicrobial 
substances into the growth media. As a result, the bacterial 
growth media was fi ltered and tested for antimicrobial 
effects against two indicator bacteria, namely E. coli and 
S. aureus. Table 2 summarizes the diameters of inhibition 
zones formed by antimicrobial substances secreted by 
isolates A1, A2, B4 and C1 against the two indicator 
bacteria. The positive control, ampicillin produced 
inhibition zones of 17.50 + 0.71 and 19.50 + 0.71 mm 
in response to E. coli and S. aureus, respectively. These 
readings were in accordance to that recommended by 
EUCAST (Matuschek et al. 2013) and thus validated the 
reliability of the test results. 
The sizes of inhibition zones formed varied among 
the isolates regardless of the indicator bacteria. This 
is speculated to be attributable to different levels of 
antimicrobial substances secreted into the growth media 
by the isolates since the level of antimicrobial substances 
produced by probiotic bacteria has been shown to be 
strain-dependent by Hartmann et al. (2011). Some 
isolates (A2 and B4) also formed larger inhibition zones 
against E. coli than S. aureus. This observation could be 
explained by differences in membrane compositions of 
S. aureus (gram positive) and E. coli (gram negative). 
The membranes of gram negative bacteria are exposed 
directly to the exteriors whereas the gram positive 
bacterial membranes are surrounded by thick cell walls 
which lead to slightly lower sensitivity of S. aureus to LAB 
antimicrobial substances (Fimland et al. 2002). Among 
the four isolates, C1 showed the highest inhibition against 
E. coli (17.50 + 0.71 mm) and S. aureus (17.85 + 0.21 
mm). The inhibition zone produced by C1 in response to 
E. coli was indifferent from that produced by ampicillin 
(p > 0.05, 17.50 + 0.71 mm) The inhibition zone diameter 
produced by C1 against S. aureus, on the other hand, was 
smaller than that of ampicillin (p < 0.05, 19.50 + 0.71 mm). 
Despite forming smaller inhibition zones against E. coli 
and S. aureus than C1, isolates A1, A2 and B4 were still 
effective in preventing the growth of E. coli and S. aureus 
FIGURE 1. Viable bacterial counts (log CFU/ml) after pH 3-6 treatments. There were only isolates A1, A2, B4 and C1 survived pH 
3-6. The test was performed in triplicate. The results were recorded as log mean CFU/ml ± s.d.
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with inhibition zone diameters ranging from 12.50+0.71 
to 16.25 + 0.35 mm (Table 2). Overall, isolates A1, A2, B4 
and C1 were capable of producing antimicrobial substances 
to prevent the growth of E. coli and S. aureus despite 
variations in the inhibition zone diameters.
16s rDNA SEQUENCING AND PHYLOGENETIC 
TREE RECONSTRUCTION
Coeuret et al. (2004) reported that there are a number of 
probiotic products containing different probiotic strains 
than claimed. Since health benefi ts conferred by probiotic 
microorganisms are strain-dependent, it is therefore crucial 
to authenticate the bacterial strains added to probiotic 
products. 16S rDNA sequencing was employed to identify 
the probiotic strains in this study. This method has been 
proven to be effective in detecting and identifying a wide 
range of organisms in cultures or clinical specimens 
(Rampini et al. 2011). The 16s rDNA was amplifi ed and 
sequenced and the results were compared with the existing 
sequences in the GenBank database and tabulated in 
Table 3. The results showed that all of the isolates were 
Lactobacillus with 98-99% homology except C1 (96%) 
(Table 3). The identifi ed LAB were also compared with the 
probiotic strains claimed by manufacturers on the product 
labels (Table 1). Drink A was claimed to contain only 
Lactobacillus casei (L. casei) and this was largely agreeable 
to that identifi ed in this study in which isolates A1-A4 
were L. casei. However, the bacteria isolated from drink 
B were different from the claimed ones. They constituted 
mostly of L. casei except isolate B1 (L. paracasei) while 
L. acidophilus and Bifi dobacterium lactis (B. lactis) DR10 
were claimed to be added to drink B. This incompatibility 
was similar to that reported by Coeuret et al. (2004) in 
which many probiotic products were found to contain 
probiotic strains that were different from the claimed ones. 
Hence, it emphasizes the importance of carrying out this 
study in order to authenticate the probiotic strains used to 
manufacture the selected probiotic drinks in Malaysia. 
L. casei and L. acidophilus were claimed to be added 
to drink C; however, there was only L. casei isolated in 
this study. This is largely due a relatively lower proportion 
of L. acidophilus added to drink C as compared to L. casei 
which in turn lowered the successful rate for L. acidophilus 
isolation (Bailey et al. 1979). Furthermore, Temmerman et 
al. (2002) also suggested that a higher successful rate for 
microorganism isolation could also be achieved by using 
a larger number of isolates. The isolation of L. acidophilus 
TABLE 2. Growth inhibition of isolates A1, A2, B4 and C1 against E. coli and S. aureus
 Isolates             Inhibition zone diameters (mm)
  E. coli S. aureus
 A1 14.25 ± 0.35 14.25 ± 1.1
 A2 14.15 ± 0.21 12.50 ± 0.71
 B4 16.25 ± 0.35 14.25 ± 0.35
 C1 17.50 ± 0.71a 17.85 ± 0.21b
 Ampicillin 17.50 ± 0.71 19.50 ± 0.71
The test was performed in triplicate. The results were stated as mean inhibitory zone ± s.d
a The inhibition zone diameter was insignifi cantly different (p > 0.05) from that produced by ampicillin against 
 E. coli
b The inhibition zone diameters were signifi cantly different (p < 0.05) from that produced by ampicillin against
 S. aureus
TABLE 3. Bacterial strains of the isolates and their sequence homologies (%) compared to that in the GeneBank Database
 Isolates Bacterial strains Homology (%)+
 A1 Lactobacillus casei 99
 A2 Lactobacillus casei 98
 A3 Lactobacillus casei 99
 A4 Lactobacillus casei 99
 B1 Lactobacillus paracasei 99
 B2 Lactobacillus casei 99
 B3 Lactobacillus casei 99
 B4 Lactobacillus casei 99
 C1 Lactobacillus casei 96
 C2 Lactobacillus casei 98
 C3 Lactobacillus casei 99
 C4 Lactobacillus casei 99
+Homology was recorded according to that shown in the BLAST
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can hence be improved by selecting greater numbers of 
LAB colonies.
A phylogenetic tree (Figure 2) was also reconstructed 
in order to further illustrate the closeness of the isolates 
to Lactobacillus. Phylogeny fr. was employed in the 
phylogenetic tree reconstruction due to its robustness, 
reliability and less-laboriousness (Dereeper et al. 2008). 
Two outgroups, namely L. acidophilus and Bifi dobacterium 
longum (B. longum) subsp. infantis ATCC 15697 were 
included in the phylogenetic tree. These two outgroups 
were selected based on, (i) B is claimed to contain L. 
acidophilus and Bifi dobacterium, (ii) C is claimed to 
contain L. acidophilus and L. casei and (iii) they are 
commonly used probiotic strains (Settanni and Moschetti, 
2010). Figure 2 illustrates that A1-C4 were closely related 
to L. casei and L. paracasei but not the outgroups. The 
genetic change score was relatively lower (0.081) than 
the outgroups (0.116 for L acidophilus and 0.308 for B. 
longum subsp. infantis ATCC 15697). The results were also 
in accordance to the gene sequencing results in which the 
16s rDNA sequences of A1-C4 were highly homologous to 
that of L. casei and L. paracasei. It is therefore confi rmed 
that the isolates were L. casei (A1-A4, B2-B4 and C1-C4) 
or L. paracasei (B1). 
CONCLUSION
Validation of probiotic product content is essential to ensure 
the quality and reliability of the products. This study has 
shown that probiotic drinks are possible to contain different 
probiotic counts and strains than claimed as observed in 
isolates obtained from drink B. The recovered bacterial 
count was 4 log CFU/ml lower than drinks A and C. Among 
the isolates, there were only A1, A2, B4 and C1 surviving 
the gastric pH besides showing effective antimicrobial 
activities. In conclusion, probiotic food contents maybe 
differ from that of labelled and the differences are possible 
to affect probiotic health benefi ts to consumers. Hence a 
stringent and precise labeling policy should be reinforced 
in the production of probiotic products.
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FIGURE 2. The phylogenetic tree of the twelve isolates (L. casei and L. paracasei), L. acidophilus and Bifi dobacterium longum 
subsp. infantis ATCC 15697. The line segment labeled with ‘0.2’ indicates an amount genetic change of 0.2 (the number of 
nucleotide changes divided by the length of sequence). Isolates A1 to C4 were closely related to the Lactobacillus 
genus, especially L. casei and L. paracasei
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